Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells

Moses K. Donkor, Elaine Lahue, Traci A. Hoke, Laura R. Shafer, Ugur Coskun, Joyce C Solheim, Dumrul Gulen, John Bishay, James E Talmadge

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

The tumor microenvironment is heterogeneous for the expansion and infiltration by myeloid derived suppressor cells (MDSCs) which has been hypothesized to be dependent on tumor burden. We report a relationships between tumor size, MDSCs and T-cells; using four murine mammary tumors to assess tumor growth, infiltration and gene expression. Our analysis of cellular infiltration into tumors and gene expression used collagenase dissociated tumors and density gradient isolation of non-parenchymal cells (NPCs). The frequency of splenic and peripheral blood (PB) MDSCs was tumor dependent resulting in a significantly increased number of MDSCs. The MDSC frequency inversely correlated with the frequency of CD3+ lymphocytes in the spleen, independent of the tumor studied and directly correlated with tumor burden. Tumor growth up-regulated cyclooxygenase-2 (COX-2), vascular endothelial growth factor-A (VEGF-A), granulocyte (G-) and granulocyte-monocyte-colony stimulating factor (GM-CSF), arginase-1 (ARG-1), and nitric oxide synthase-2 (NOS-2) transcription in the tumor and spleens (not VEGF-A). The frequency of splenic MDSCs directly correlated with splenic COX-2, NOS-2, and ARG-1 message levels, while COX-2 and NOS-2 transcript levels inversely correlated with splenic CD3+ cell frequency. COX-2 mRNA levels also directly correlated with the ARG-1 and NOS-2 transcript levels from tumor-infiltrating leukocytic cells, supporting prostaglandin E2 as a regulator of ARG-1 and NOS-2 transcription. In summary, MDSC numbers in the spleen and tumor microenvironment are tumor dependent, directly correlating with tumor size and inversely correlating with T-cell number. MDSCs are also directly associated with VEGF-A and G-CSF transcript levels suggesting multiple mechanisms for MDSC regulation and COX-2, NOS-2 and ARG-1 supporting multiple mechanisms of T-cell suppression.

Original languageEnglish (US)
Pages (from-to)937-948
Number of pages12
JournalInternational Immunopharmacology
Volume9
Issue number7-8
DOIs
StatePublished - Jul 1 2009

Fingerprint

Breast Neoplasms
Arginase
Nitric Oxide Synthase
Cyclooxygenase 2
Neoplasms
Vascular Endothelial Growth Factor A
Tumor Microenvironment
Spleen
Granulocyte Colony-Stimulating Factor
Tumor Burden
T-Lymphocytes
Myeloid-Derived Suppressor Cells
Cell Count
Gene Expression
Macrophage Colony-Stimulating Factor
Collagenases
Growth
Dinoprostone
Granulocytes
Monocytes

Keywords

  • Dendritic cells
  • Immune suppression
  • MDSCs
  • Mammary tumors
  • T-cells

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this

Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells. / Donkor, Moses K.; Lahue, Elaine; Hoke, Traci A.; Shafer, Laura R.; Coskun, Ugur; Solheim, Joyce C; Gulen, Dumrul; Bishay, John; Talmadge, James E.

In: International Immunopharmacology, Vol. 9, No. 7-8, 01.07.2009, p. 937-948.

Research output: Contribution to journalArticle

Donkor, Moses K. ; Lahue, Elaine ; Hoke, Traci A. ; Shafer, Laura R. ; Coskun, Ugur ; Solheim, Joyce C ; Gulen, Dumrul ; Bishay, John ; Talmadge, James E. / Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells. In: International Immunopharmacology. 2009 ; Vol. 9, No. 7-8. pp. 937-948.
@article{60077e2f1c324a7b85b3922c58953936,
title = "Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells",
abstract = "The tumor microenvironment is heterogeneous for the expansion and infiltration by myeloid derived suppressor cells (MDSCs) which has been hypothesized to be dependent on tumor burden. We report a relationships between tumor size, MDSCs and T-cells; using four murine mammary tumors to assess tumor growth, infiltration and gene expression. Our analysis of cellular infiltration into tumors and gene expression used collagenase dissociated tumors and density gradient isolation of non-parenchymal cells (NPCs). The frequency of splenic and peripheral blood (PB) MDSCs was tumor dependent resulting in a significantly increased number of MDSCs. The MDSC frequency inversely correlated with the frequency of CD3+ lymphocytes in the spleen, independent of the tumor studied and directly correlated with tumor burden. Tumor growth up-regulated cyclooxygenase-2 (COX-2), vascular endothelial growth factor-A (VEGF-A), granulocyte (G-) and granulocyte-monocyte-colony stimulating factor (GM-CSF), arginase-1 (ARG-1), and nitric oxide synthase-2 (NOS-2) transcription in the tumor and spleens (not VEGF-A). The frequency of splenic MDSCs directly correlated with splenic COX-2, NOS-2, and ARG-1 message levels, while COX-2 and NOS-2 transcript levels inversely correlated with splenic CD3+ cell frequency. COX-2 mRNA levels also directly correlated with the ARG-1 and NOS-2 transcript levels from tumor-infiltrating leukocytic cells, supporting prostaglandin E2 as a regulator of ARG-1 and NOS-2 transcription. In summary, MDSC numbers in the spleen and tumor microenvironment are tumor dependent, directly correlating with tumor size and inversely correlating with T-cell number. MDSCs are also directly associated with VEGF-A and G-CSF transcript levels suggesting multiple mechanisms for MDSC regulation and COX-2, NOS-2 and ARG-1 supporting multiple mechanisms of T-cell suppression.",
keywords = "Dendritic cells, Immune suppression, MDSCs, Mammary tumors, T-cells",
author = "Donkor, {Moses K.} and Elaine Lahue and Hoke, {Traci A.} and Shafer, {Laura R.} and Ugur Coskun and Solheim, {Joyce C} and Dumrul Gulen and John Bishay and Talmadge, {James E}",
year = "2009",
month = "7",
day = "1",
doi = "10.1016/j.intimp.2009.03.021",
language = "English (US)",
volume = "9",
pages = "937--948",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",
number = "7-8",

}

TY - JOUR

T1 - Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells

AU - Donkor, Moses K.

AU - Lahue, Elaine

AU - Hoke, Traci A.

AU - Shafer, Laura R.

AU - Coskun, Ugur

AU - Solheim, Joyce C

AU - Gulen, Dumrul

AU - Bishay, John

AU - Talmadge, James E

PY - 2009/7/1

Y1 - 2009/7/1

N2 - The tumor microenvironment is heterogeneous for the expansion and infiltration by myeloid derived suppressor cells (MDSCs) which has been hypothesized to be dependent on tumor burden. We report a relationships between tumor size, MDSCs and T-cells; using four murine mammary tumors to assess tumor growth, infiltration and gene expression. Our analysis of cellular infiltration into tumors and gene expression used collagenase dissociated tumors and density gradient isolation of non-parenchymal cells (NPCs). The frequency of splenic and peripheral blood (PB) MDSCs was tumor dependent resulting in a significantly increased number of MDSCs. The MDSC frequency inversely correlated with the frequency of CD3+ lymphocytes in the spleen, independent of the tumor studied and directly correlated with tumor burden. Tumor growth up-regulated cyclooxygenase-2 (COX-2), vascular endothelial growth factor-A (VEGF-A), granulocyte (G-) and granulocyte-monocyte-colony stimulating factor (GM-CSF), arginase-1 (ARG-1), and nitric oxide synthase-2 (NOS-2) transcription in the tumor and spleens (not VEGF-A). The frequency of splenic MDSCs directly correlated with splenic COX-2, NOS-2, and ARG-1 message levels, while COX-2 and NOS-2 transcript levels inversely correlated with splenic CD3+ cell frequency. COX-2 mRNA levels also directly correlated with the ARG-1 and NOS-2 transcript levels from tumor-infiltrating leukocytic cells, supporting prostaglandin E2 as a regulator of ARG-1 and NOS-2 transcription. In summary, MDSC numbers in the spleen and tumor microenvironment are tumor dependent, directly correlating with tumor size and inversely correlating with T-cell number. MDSCs are also directly associated with VEGF-A and G-CSF transcript levels suggesting multiple mechanisms for MDSC regulation and COX-2, NOS-2 and ARG-1 supporting multiple mechanisms of T-cell suppression.

AB - The tumor microenvironment is heterogeneous for the expansion and infiltration by myeloid derived suppressor cells (MDSCs) which has been hypothesized to be dependent on tumor burden. We report a relationships between tumor size, MDSCs and T-cells; using four murine mammary tumors to assess tumor growth, infiltration and gene expression. Our analysis of cellular infiltration into tumors and gene expression used collagenase dissociated tumors and density gradient isolation of non-parenchymal cells (NPCs). The frequency of splenic and peripheral blood (PB) MDSCs was tumor dependent resulting in a significantly increased number of MDSCs. The MDSC frequency inversely correlated with the frequency of CD3+ lymphocytes in the spleen, independent of the tumor studied and directly correlated with tumor burden. Tumor growth up-regulated cyclooxygenase-2 (COX-2), vascular endothelial growth factor-A (VEGF-A), granulocyte (G-) and granulocyte-monocyte-colony stimulating factor (GM-CSF), arginase-1 (ARG-1), and nitric oxide synthase-2 (NOS-2) transcription in the tumor and spleens (not VEGF-A). The frequency of splenic MDSCs directly correlated with splenic COX-2, NOS-2, and ARG-1 message levels, while COX-2 and NOS-2 transcript levels inversely correlated with splenic CD3+ cell frequency. COX-2 mRNA levels also directly correlated with the ARG-1 and NOS-2 transcript levels from tumor-infiltrating leukocytic cells, supporting prostaglandin E2 as a regulator of ARG-1 and NOS-2 transcription. In summary, MDSC numbers in the spleen and tumor microenvironment are tumor dependent, directly correlating with tumor size and inversely correlating with T-cell number. MDSCs are also directly associated with VEGF-A and G-CSF transcript levels suggesting multiple mechanisms for MDSC regulation and COX-2, NOS-2 and ARG-1 supporting multiple mechanisms of T-cell suppression.

KW - Dendritic cells

KW - Immune suppression

KW - MDSCs

KW - Mammary tumors

KW - T-cells

UR - http://www.scopus.com/inward/record.url?scp=65849343816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65849343816&partnerID=8YFLogxK

U2 - 10.1016/j.intimp.2009.03.021

DO - 10.1016/j.intimp.2009.03.021

M3 - Article

C2 - 19362167

AN - SCOPUS:65849343816

VL - 9

SP - 937

EP - 948

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

IS - 7-8

ER -